CCM2 Antikörper
(1 reference)-
- Target Alle CCM2 Antikörper anzeigen
- CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCM2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of CCM2.
- Sequenz
- C-KGEKSRDKKA HEK
- Spezifität
- This antibody is expected to recognize both reported isoforms (NP_001025006.1 and NP_113631.1).
- Kreuzreaktivität
- Hund, Human, Maus, Ratte
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human CCM2.
- Top Product
- Discover our top product CCM2 Primärantikörper
-
anti-Cerebral Cavernous Malformation 2 (CCM2) (Internal Region) antibody
Verified CCM2 Reaktivität: Human, Ratte WB, IF, ELISA, FACS Wirt: Ziege Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) (AA 1-300) antibodyCCM2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) antibodyCCM2 Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) (AA 1-444) antibodyCCM2 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) (AA 1-300) antibodyCCM2 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) (AA 2-100) antibodyCCM2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) (AA 1-444) antibodyCCM2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) antibodyCCM2 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cerebral Cavernous Malformation 2 (CCM2) (AA 1-444), (N-Term) antibodyCCM2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:128000)
Western Blot (0.03-0.1 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis." in: Human molecular genetics, Vol. 14, Issue 17, pp. 2521-31, (2005) (PubMed).
-
: "CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis." in: Human molecular genetics, Vol. 14, Issue 17, pp. 2521-31, (2005) (PubMed).
-
- Target
- CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
- Andere Bezeichnung
- Malcavernin (CCM2 Produkte)
- Synonyme
- C7orf22 antikoerper, OSM antikoerper, malcavernin antikoerper, CCM2 antikoerper, BC029157 antikoerper, TUF2 antikoerper, vtn antikoerper, zgc:110233 antikoerper, CCM2 scaffolding protein antikoerper, cerebral cavernous malformation 2 antikoerper, malcavernin antikoerper, CCM2 antikoerper, Ccm2 antikoerper, LOC100304744 antikoerper, ccm2 antikoerper
- Gen-ID
- 83605
- Pathways
- Cell-Cell Junction Organization
-
